Screener
Celldex Therapeutics CLDX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Celldex Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
FAQ
- What is Celldex Therapeutics's price / sales?
- Celldex Therapeutics (CLDX) reported price / sales of 18,485.4× in Q2 2026.
- How has Celldex Therapeutics's price / sales changed year-over-year?
- Celldex Therapeutics's price / sales increased by 7347.2% year-over-year, from 248.2× to 18,485.4×.
- What is the long-term trend for Celldex Therapeutics's price / sales?
- Over 5 years (2020 to 2025), Celldex Therapeutics's price / sales has grown at a 60.3% compound annual growth rate (CAGR), from 110.2× to 1,167.4×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Celldex Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude